Novel Experimental COVID-19 Therapies Affecting Host Response

Clinical trial NCT04924660 · COMPLETED

Trial details

NCT number: NCT04924660
Sponsor: Sean Collins
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 SARS-CoV-2 Infection Coronavirus Infection

Start date: 2021-07-15
Primary completion: 2023-10-25
Enrollment: 1060

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.